Ceroid Lipofuscinosis Neuronal Kufs Type Adult Onset Cn260133
A rare inherited disorder where fatty substances build up in nerve cells, causing progressive movement problems, memory loss, and cognitive decline in adults. There is no cure, so treatment focuses on managing symptoms and providing supportive care.
Key facts at a glance
- ICD-10
- G31.82
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Focal seizures
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Personality changes
(neurologic)Dysphagia
(neurologic)Cerebellar ataxia
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Adult-onset NCL surveillance program
Specialized monitoring for adult patients with progressive neurological decline, including cognitive assessments, motor function evaluation, and psychiatric symptom screening. Regular follow-up with neurology specialists experienced in adult-onset presentations.
Drug therapy and clinical monitoring
Active treatment with regular monitoring by a healthcare provider is recommended.
Symptom-targeted pharmacotherapy
Medication management tailored to adult-onset symptoms, which may include movement disorders, psychiatric manifestations, and seizures. Treatment protocols are adapted from pediatric NCL guidelines with consideration for adult-specific factors.
Additional treatment options
Psychiatric and mental health support
Mental health services address the significant psychological burden of progressive neurological disease in adults. Treatment includes therapy for depression, anxiety, and behavioral changes associated with cognitive decline.
psychologicalActivity maintenance and independence programs
Encouraging continued engagement in meaningful activities while adapting to progressive limitations. Programs focus on maximizing independence through environmental modifications and assistive devices.
lifestylePalliative and supportive care integration
Early integration of palliative care services to address quality of life concerns, advance care planning, and symptom management. Coordination with primary neurology team ensures comprehensive support.
complementaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Ceroid Lipofuscinosis Neuronal Kufs Type Adult Onset Cn260133?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Mole SE, Williams RE, Goebel HH. The neuronal ceroid lipofuscinoses (Batten disease). Handb Clin Neurol. 2013.
Nita DA, Mole SE, Minassian BA. Guidelines for the diagnosis and management of neuronal ceroid lipofuscinosis. Can J Neurol Sci. 2016.
Kurano M, Saito N, Hara M, et al. Adult-onset neuronal ceroid lipofuscinosis with palmitoyl protein thioesterase and prosaposin mutations. J Neurol Sci. 2022.
Ousley O, Steiner Z, Brault S, et al. Clinical phenotype and natural history of Kufs disease type A. Neurology. 2019.
Medication Comparisons
Compare medications used to treat Ceroid Lipofuscinosis Neuronal Kufs Type Adult Onset Cn260133. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy